Audit of cardiovascular disease risk factors among supported adults with intellectual disability attending an ageing clinic

References

• Access Economics. The shifting burden of cardiovascular disease in Australia. 2005, The National Heart Foundation: Canberra, Australia
   Google Scholar
• Australian Institute of Health and Welfare (AIHW). Heart, stroke and vascular diseases – Australian facts 2004. AIHW, Canberra 2004, AIHW Cat. No. CVD 27. (Expenditure Series, No. 19; Cardiovascular Disease Series, No. 22)
   Google Scholar
• Barker D. The intrauterine environment and adult cardiovascular disease. The childhood environment and adult disease. Wiley, Chichester 1991; 3–16, (Ciba Foundation Symposia Series, No. 156)
   Google Scholar
• Beange H., McElduff A., Baker W. Medical disorders of adults with mental retardation: A population study. American Journal of Mental Retardation 1995; 99: 595–604
   PubMedGoogle Scholar
• Bisoendial R. J., Kastelein J. J., Levels J. H., Zwaginga J. J., van den Bogaard B., Reitsma P. H., et al. Activation of inflammation and coagulation after infusion of C‐reactive protein in humans. Circulation Research ISE: 1524 4571 2005; 96: 714–716
   Google Scholar
• Bunker S., Colquhoun D., Esler M. Stress and coronary heart disease: Psychosocial risk factors. National Heart Foundation of Australia position statement update. Medical Journal of Australia 2003; 178: 272–276
   PubMed Web of Science ®Google Scholar
• Casey D. Dyslipidemia and atypical antipsychotic drugs. The Journal of Clinical Psychiatry 2004; 65: 27–35
   PubMed Web of Science ®Google Scholar
• Chaney R. H. Neurogenic atherosclerosis in mentally retarded persons. Journal of Mental Deficiency Research 1987; 31: 235–240
   PubMedGoogle Scholar
• Draheim C. C., McCubbin J. A., Williams D. P. Differences in cardiovascular disease risk between nondiabetic adults with mental retardation with and without Down syndrome. American Journal of Mental Retardation 2002; 107: 201–211
   PubMedGoogle Scholar
• Dunstan D., Zimmet P., Welborn T., Cameron A., Shaw J., de Courten M., et al. The Australian Diabetes, Obesity and Lifestyle Study (AusDiab) ‐ Methods and response rates. Diabetes Research and Clinical Practice 2002; 57: 119–129
   PubMed Web of Science ®Google Scholar
• Dunstan D., Zimmet P., Welborn T., de Courten M., Cameron A., Sicree R., et al. The rising prevalence of diabetes and impaired glucose tolerance: The Australian Diabetes, Obesity and Lifestyle Study. Diabetes Care 2002; 25: 829–834
   PubMed Web of Science ®Google Scholar
• Dupont A., Vaeth M., Videbech P. Mortality, life expectancy and causes of death of mildly mentally retarded in Denmark. Upsala Journal of Medical Sciences 1987; 44(Supplement): 29–82
   Google Scholar
• Haust M. D. Arterial involvement in genetic diseases. The American Journal of Cardiovascular Pathology 1987; 1: 231–286
   PubMedGoogle Scholar
• Hofman P., Cutfield W. Insulin sensitivity in people born pre‐term, with low or very low birth weight and small for gestational age. Journal of Endocrinological Investigation 2006; 29: 2–8
   PubMedGoogle Scholar
• Hymowitz N., Jaffe F., Gupta A., Feuerman M. Cigarette smoking among patients with mental retardation and mental illness. Psychiatric Services 1997; 48: 100–102
   PubMed Web of Science ®Google Scholar
• Janicki M. P., Dalton A., Henderson C. M., Davidson P. W. Mortality and morbidity among older adults with intellectual disability: Health services considerations. Disability and Rehabilitation 1999; 21: 284–294
   PubMed Web of Science ®Google Scholar
• Janicki M. P., Davidson P. W., Henderson C. M., McCallion P., Taets J. D., Force L. T., et al. Health characteristics and health services utilization in older adults with intellectual disability living in community residences. Journal of Intellectual Disability Research 2002; 46: 287–298
   PubMed Web of Science ®Google Scholar
• Kapell D., Nightingale B., Rodriguez A., Lee J., Zigman W., Schupf N. Prevalence of chronic medical conditions in adults with mental retardation: Comparison with the general population. Mental Retardation 1998; 36((4))269–279
   PubMedGoogle Scholar
• Krams R., Segers D., Gourabi B. M., Maat W., Cheng C., van Pelt C., et al. Inflammation and atherosclerosis: Mechanisms underlying vulnerable plaque. Journal of Interventional Cardiology 2003; 16: 107–113
   PubMedGoogle Scholar
• Marlow N., Wolke D., Bracewell M., Samara M. Neurologic and developmental disability at six years of age after extremely preterm birth. The New England Journal of Medicine 2005; 352: 9–19
   PubMed Web of Science ®Google Scholar
• National Vascular Disease Prevention Alliance. Consensus statement for the prevention of vascular disease. 2004, Available at: http://www.heartfoundation.org.au/document/NHF/nvdpa_04.pdf
   Google Scholar
• New Zealand Guidelines Group. Cardiovascular Risk Calculator. Assessing cardiovascular risk and treatment benefit. National Prescribing Service, Surry Hills, Sydney 2005
   Google Scholar
• Newcomer J. Abnormalities of glucose metabolism associated with atypical antipsychotic drugs. The Journal of Clinical Psychiatry 2004; 65: 36–46
   PubMedGoogle Scholar
• Pueschel S. M., Craig W. Y., Haddow J. E. Lipids and lipoproteins in persons with Down's syndrome. Journal of Intellectual Disability Research 1992; 36: 365–369
   PubMed Web of Science ®Google Scholar
• Rimmer J., Braddock D., Fujiura G. Prevalence of obesity in adults with mental retardation: Implications for health promotion and disease prevention. Mental Retardation 1993; 31: 105–110
   PubMedGoogle Scholar
• Rimmer J. H., Braddock D., Fujiura G. Cardiovascular risk factor levels in adults with mental retardation. American Journal of Mental Retardation 1994; 98: 510–518
   PubMedGoogle Scholar
• Scheepers M., Kerr M., O'Hara D., Bainbridge D., Cooper S. A., Davis R., et al. Reducing health disparity in people with intellectual disabilities. Journal of Policy and Practice in Intellectual Disabilities 2005; 2: 249–255
   Google Scholar
• Statacorp. Stata Statistical Software Release 8.0. Stata Press, College Station, TX 2003, [Computer package]
   Google Scholar
• Taggart L., McLaughlin D., Quinn B., Milligan V. An exploration of substance misuse in people with intellectual disabilities. Journal of Intellectual Disability Research 2006; 50: 588–598
   PubMed Web of Science ®Google Scholar
• Tracy J., Hosken R. The importance of smoking education and preventative health strategies for people with intellectual disability. Journal of Intellectual Disability Research 1997; 41: 416–421
   PubMed Web of Science ®Google Scholar
• van Schrojenstein Lantman de Valk H. M., van den Akker M., Maaskant M. A., Haveman M. J., Urlings H. F., Kessels A. G., Crebolder H. F. Prevalence and incidence of health problems in people with intellectual disability. Journal of Intellectual Disability Research 1997; 41: 42–51
   PubMedGoogle Scholar
• Wallace R. Biopsychosocial profile of adults with ID. Medical Journal of Australia 2001; 174: 200–201
   PubMed Web of Science ®Google Scholar
• Wallace R. A. Risk factors for coronary artery disease among individuals with rare syndrome intellectual disabilities. Journal of Policy and Practice in Intellectual Disabilities 2004; 1: 42–51
   Google Scholar
• Wallace R. A., Webb P. M., Schluter P. J. Environmental, medical, behavioural and disability factors associated with Helicobacter pylori infection in adults with intellectual disability. Journal of Intellectual Disability Research 2002; 46: 51–60
   PubMed Web of Science ®Google Scholar
• Wirshing D. Schizophrenia and obesity: Impact of antipsychotic medications. The Journal of Clinical Psychiatry 2004; 65: 13–26
   PubMed Web of Science ®Google Scholar